Martingale Asset Management L P Protagonist Therapeutics, Inc Transaction History

Martingale Asset Management L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$17.63 - $37.1 $306,903 - $645,836	-17,408 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$12.95 - $49.69 $117,845 - $452,179	9,100 Added 109.53%	17,408 $308,000
Q2 2021 Aug 13, 2021	BUY	$25.57 - $44.88 $212,435 - $372,863	8,308 New	8,308 $372,000
Q4 2020 Feb 10, 2021	SELL	$18.49 - $25.13 $808,012 - $1.1 Million	-43,700 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$15.19 - $22.4 $812,665 - $1.2 Million	-53,500 Reduced 55.04%	43,700 $854,000
Q2 2020 Aug 10, 2020	BUY	$6.19 - $18.84 $601,668 - $1.83 Million	97,200 New	97,200 $1.72 Million

212

59.1M

19K

107K

Ticker PTGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,084,100
Market Cap $2.25B
Description
Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.